Nazende Günday-Türeli (Nazende Günday Türeli)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Nanoscale

Beilstein journal of nanotechnology

Polymers

Pharmaceutics

MyBiotech GmbH

Saarland University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

MyBiotech GmbH Feb 01 2020

Germany

Head of R&D Pharma :: R&D Pharma

MJR PharmJet GmbH Oct 01 2010 - Jan 31 2020

Germany

Team Leader R&D :: R&D

Across Barriers GmbH Aug 01 2008 - Sep 30 2010

Germany

Project Manager :: R&D

Abdi İbrahim İlac Sanayi ve Tic AS Jul 01 2004 - Jul 31 2008

Turkey

R&D Specialist :: R&D

Education History

Saarland University Oct 01 2014 - May 17 2017

Germany

PHD :: Biopharmaceutics and Phamaceutical Nanotechnology

Saarland University Sep 01 2010 - Jan 15 2013

Germany

MSC :: Biotechnology

Publications

Nikša Drinković, Maja Beus, Rinea Barbir, Željko Debeljak, Blanka Tariba Lovaković, Nikolina Kalčec, Marija Ćurlin, Ana Bekavac, Dunja Gorup, Ivan Mamić, Dario Mandić, Vedran Micek, Petra Turcic, Nazende Günday-Türeli, Emre Türeli, Ivana Vinković Vrček
Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity. Nanoscale (2024)
Nikša Drinković, Maja Beus, Rinea Barbir, Željko Debeljak, Blanka Tariba Lovaković, Nikolina Kalčec, Marija Ćurlin, Ana Bekavac, Dunja Gorup, Ivan Mamić, Dario Mandić, Vedran Micek, Petra Turcic, Nazende Günday-Türeli, Emre Türeli, Ivana Vinković Vrček
Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity. Nanoscale 16 (19) (2024)
Bahareh Azimi, Claudio Ricci, Teresa Macchi, Cemre Günday, Sara Munafò, Homa Maleki, Federico Pratesi, Veronika Tempesti, Caterina Cristallini, Luca Bruschini, Andrea Lazzeri, Serena Danti, Nazende Günday-Türeli
A Straightforward Method to Produce Multi-Nanodrug Delivery Systems for Transdermal/Tympanic Patches Using Electrospinning and Electrospray. Polymers 15 (17) (2023)
Željko Debeljak, Ivana Vinković Vrček, Nikša Drinković, Vedran Micek, Emerik Galić, Dunja Gorup, Marija Ćurlin, Dario Mandić, Ana Bandjak, Barbara Pem, Nikolina Kalčec, Krunoslav Ilić, Ivan Pavičić, Suzana Mimica, Nazende Günday-Türeli, Emre Türeli
Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues. The Analyst 147 (14) (2022)
Lara Zorić, Nikša Drinković, Vedran Micek, Leo Frkanec, Akif Emre Türeli, Nazende Günday-Türeli, Ivana Vinković Vrček, Ruža Frkanec
High-Throughput Method for the Simultaneous Determination of Doxorubicin Metabolites in Rat Urine after Treatment with Different Drug Nanoformulations. Molecules (Basel, Switzerland) 27 (4) (2022)
Jennifer Oberländer, Rafael Ayerbe, Joan Cabellos, Richard da Costa Marques, Bin Li, Nazende Günday-Türeli, Akif Emre Türeli, Racheli Ofir, Eliran Ish Shalom, Volker Mailänder
Higher Loading of Gold Nanoparticles in PAD Mesenchymal-like Stromal Cells Leads to a Decreased Exocytosis. Cells 11 (15) (2022)
Fiorenza Rancan, Jana Jurisch, Cemre Günday, Akif Emre Türeli, Ulrike Blume-Peytavi, Annika Vogt, Christoph Schaudinn, Nazende Günday-Türeli
Screening of Surfactants for Improved Delivery of Antimicrobials and Poly-Lactic-co-Glycolic Acid Particles in Wound Tissue. Pharmaceutics 13 (7) (2021)
Sonia M Lombardo, Marc Schneider, Akif E Türeli, Nazende Günday-Türeli
Key for crossing the BBB with nanoparticles: the rational design. Beilstein journal of nanotechnology 11 (2020)

Nazende Günday-Türeli.css-eqlu8i{font-size:small;padding-left:4px;} (Nazende Günday Türeli)

Publication Activity (10 Years)

Top Topics

Top Venues

Nazende Günday-Türeli (Nazende Günday Türeli)